TLX logo

TLX
Telix Pharmaceuticals Limited American Depositary Shares

98
Mkt Cap
$3.58B
Volume
177,697.00
52W High
$18.99
52W Low
$6.28
PE Ratio
-500.47
TLX Fundamentals
Price
$10.56
Prev Close
$10.19
Open
$10.30
50D MA
$8.57
Beta
0.00
Avg. Volume
284,289.89
EPS (Annual)
-$0.0211
P/B
8.61
$2,855.96
Loading...
Loading...
News
all
press releases
Regeneron Boosts Cancer Pipeline Through Telix Collaboration
Regeneron teams up with Telix in a 50/50 radiopharma deal, betting on next-gen cancer therapies to expand its oncology pipeline and long-term growth.
Zacks·12d ago
News Placeholder
More News
News Placeholder
Telix Pharmaceuticals (NASDAQ:TLX) Shares Gap Down - What's Next?
Telix Pharmaceuticals (NASDAQ:TLX) Shares Gap Down - Time to Sell...
MarketBeat·12d ago
News Placeholder
Telix Pharmaceuticals (NASDAQ:TLX) Shares Gap Up - Should You Buy?
Telix Pharmaceuticals (NASDAQ:TLX) Shares Gap Up - Here's Why...
MarketBeat·13d ago
News Placeholder
Wedbush Reaffirms Outperform Rating for Telix Pharmaceuticals (NASDAQ:TLX)
Wedbush reissued an "outperform" rating and set a $22.00 price target on shares of Telix Pharmaceuticals in a report on Monday...
MarketBeat·13d ago
News Placeholder
Telix Pharmaceuticals (NASDAQ:TLX) Given "Buy" Rating at HC Wainwright
HC Wainwright reiterated a "buy" rating and issued a $20.00 price target on shares of Telix Pharmaceuticals in a research report on Monday...
MarketBeat·13d ago
News Placeholder
Regeneron Pharma Partners Telix Pharma To Jointly Develop Radiopharmaceutical Therapies
(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN) and Telix Pharmaceuticals Ltd. (TLX, TLX.AX) announced Monday a collaboration to jointly develop and commercialize next generation radiopharmaceutical therapies...
Nasdaq News: Markets·13d ago
News Placeholder
Telix And Regeneron Partner To Advance Next-Generation Radiopharmaceutical Therapies
(RTTNews) - Telix Pharmaceuticals Limited (TLX, TLX.AX) and Regeneron Pharmaceuticals, Inc. (REGN) have announced a collaboration to jointly develop and commercialize next-generation...
Nasdaq News: Markets·14d ago
News Placeholder
Telix Pharmaceuticals (NASDAQ:TLX) Rating Increased to Hold at Wall Street Zen
Wall Street Zen raised Telix Pharmaceuticals from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat·16d ago
News Placeholder
Telix Pharmaceuticals (NASDAQ:TLX) Sees Strong Trading Volume - Here's Why
Telix Pharmaceuticals (NASDAQ:TLX) Sees Strong Trading Volume - Here's What Happened...
MarketBeat·16d ago
News Placeholder
TLX Stock Surges Overnight After FDA Agrees To Review Brain Cancer Imaging Agent Application
U.S.-listed shares of Telix Pharmaceuticals rose after the FDA accepted its NDA application for a brain cancer imaging agent.
Stocktwits·17d ago
<
1
2
...
>

Latest TLX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.